Published Jul 23, 2026, 9:20 PM ET · Updated 4 months ago · 2 sources

Eli Lilly-Backed Scribe Raises $128.7 Million in Upsized IPO

bloomberg

Original Report

Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, raised $128.7 million in an upsized initial public offering priced at the top of its marketed range.